Fei Yang

Anti-CD19 chimeric antigen receptors T cells for the treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: report of three cases

H. Qiu, Yue Han, Qian Wu, 2019, Leukemia & lymphoma.

Delayed remission following sequential infusion of humanized CD19- and CD22-modified CAR-T cells in a patient with relapsed/refractory acute lymphoblastic leukemia and prior exposure to murine-derived CD19-directed CAR-T cells

Depei Wu, H. Qiu, Jian Zhang, 2019, OncoTargets and therapy.

Anti-CD19 chimeric antigen receptor T-cells induce durable remission in relapsed Philadelphia chromosome-positive ALL with T315I mutation

Xiaodong Yang, A. Sun, Xiaowen Tang, 2019, Leukemia & lymphoma.

Overexpression of L 1 cell adhesion molecule correlates with aggressive tumor progression of patients with breast cancer and promotes motility of breast cancer cells

Jin-hai Tang, F. Jiao, Lin-Lin Zhen, 2015 .

Overexpression of L1 cell adhesion molecule correlates with aggressive tumor progression of patients with breast cancer and promotes motility of breast cancer cells.

Jin-hai Tang, F. Jiao, Lin-Lin Zhen, 2015, International journal of clinical and experimental pathology.

Red-emitting CsPbBrI2/PbSe heterojunction nanocrystals with high luminescent efficiency and stability for bright light-emitting diodes

Mingkui Wang, Hongting Chen, Rui Zhang, 2019 .